person · Reporting owner
Herchuk Jannie Prestridge
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Aspira Women's Health Inc.
Report date June 04, 2025 · Filed June 05, 2025
Section 16 reporting ended · disclosed 2025-06-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 82,502 |
Reported balance
After 2025-06-04 transaction · row 1
1 source rowRow 1 · 2025-06-04 · Exercise / conversion · Acquired 8,437 · Balance 82,502 F1: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-06-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-04 · Exercise / conversion · Disposed 8,437 · Balance 0 F2: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
F2: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
F3: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2025 Filed Jun 5, 2025 20:06 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 8,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-013806 · ownership.xml · derivative · entry 2 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:06 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | Exercise / conversionCommon Stock | 8,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-013806 · ownership.xml · nonDerivative · entry 1 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 22:42 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 8,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-002186 · ownership.xml · derivative · entry 2 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,437 Underlying: Common Stock · 8,438 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 22:42 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionCommon Stock | 8,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-002186 · ownership.xml · nonDerivative · entry 1 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. Read SEC document |
| December 31, 2024 Filed Jan 9, 2025 00:20 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 8,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001973204-25-000001 · primary_doc.xml · derivative · entry 2 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,875 Underlying: Common Stock · 8,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4. Read SEC document |
| December 31, 2024 Filed Jan 9, 2025 00:20 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionCommon Stock | 8,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001973204-25-000001 · primary_doc.xml · nonDerivative · entry 1 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:39 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 8,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001973204-24-000001 · primary_doc.xml · derivative · entry 2 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,312 Underlying: Common Stock · 8,438 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:39 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionCommon Stock | 8,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001973204-24-000001 · primary_doc.xml · nonDerivative · entry 1 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 11:18 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantRestricted Stock Units · Derivative | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-100341 · ownership.xml · derivative · entry 1 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,750 Underlying: Common Stock · 33,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 20:20 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 20,017 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-096259 · ownership.xml · nonDerivative · entry 1 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,752 F1 · shares: The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024. Read SEC document |
| July 09, 2024 Filed Jul 10, 2024 20:40 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantWarrant (Right to buy) · Derivative | 4,902 | Not disclosed Strike: $2.25 | Not disclosed |
DisclosureSEC source: 0000950170-24-082724 · ownership.xml · derivative · entry 2 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,902 Underlying: Common Stock, par value $0.001 · 4,902 shares Expires 2027-07-09 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53. Read SEC document |
| July 09, 2024 Filed Jul 10, 2024 20:40 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 4,902 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-082724 · ownership.xml · nonDerivative · entry 1 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,735 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53. Read SEC document |
| July 24, 2023 Filed Jul 24, 2023 22:49 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | PurchaseCommon Stock | 8,794 | $3.98 | $35,000.12 |
DisclosureSEC source: 0001973204-23-000002 · primary_doc.xml · nonDerivative · entry 1 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,833 Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:54 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 23,493 | $0.00 Strike: $2.99 | $0.00 |
DisclosureSEC source: 0001973204-23-000001 · primary_doc.xml · derivative · entry 2 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,493 Underlying: Common Stock · 23,493 shares Expires 2033-06-02 F2 · derivative.exercise_date: The employee stock option will vest in the amount of 9,367 shares on June 1, 202, 7,063 shares on September 1, 2023 and 7,063 shares on December 1, 2023. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:54 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 15,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001973204-23-000001 · primary_doc.xml · nonDerivative · entry 1 Herchuk Jannie Prestridge · CIK 0001973204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,039 F1 · shares: 3,363 of the restricted stock units will vest on June 1, 2023, 5,838 of the restricted stock units will vest on September 1, 2023 and 5,838 of the restricted stock units will vest on December 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.